Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380.
N Engl J Med. 2021.
PMID: 33761207
Clinical Trial.